Late Breaking Abstract - Online cognitive behaviour therapy for anxiety in asthma: a randomised controlled trial - Amsterdam 2025

ALERT 2: infections, lung cancer and respiratory symptoms management

Chair(s): Ioannis Vogiatzis, Francesco Blasi, Anna Salina, Thomas Wilkinson

Session type: Clinical trials session

Late Breaking Abstract - Online cognitive behaviour therapy for anxiety in asthma: a randomised controlled trial

Marianne Bonnert

EVENTS HOME

Previous presentation

Next presentation

Session content

RCT Abstract - Durvalumab, carboplatin, and etoposide in treatment-naïve patients with extensive-stage small cell lung cancer and poor performance status: A single-arm phase II NEJ045A study

Satoshi Watanabe

Replay

Abstract

Slides

RCT Abstract - Effectiveness of hypertonic saline (HTS 6%) and carbocisteine in reducing bronchiectasis exacerbations (Results of the CLEAR randomised trial)

Judy M Bradley

Replay

Abstract

Slides

RCT Abstract - Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: a prospective international meta-trial of randomised clinical studies

Frank Van Haren

Replay

Abstract

Slides

Wrap-up by discussant and discussion

Francesco Blasi

Replay

Slides

RCT Abstract - Morphine for chronic breathlessness (MABEL): a multi-site, parallel group, dose titration, double-blind, randomised, placebo-controlled trial.

Miriam Johnson

Replay

Abstract

Slides

Late Breaking Abstract - Online cognitive behaviour therapy for anxiety in asthma: a randomised controlled trial

Marianne Bonnert

Replay

Abstract

Slides

The SINFONIA study: a phase III randomised controlled trial of an online group singing intervention for people with COPD or ILD.

Natasha Smallwood

Replay

Abstract

Slides

Wrap-up by discussant and discussion

Ioannis Vogiatzis

Replay

Slides

Session aims

The ALERT sessions (Abstracts Leading to Evolution in Respiratory Medicine Trials) showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, discussants, session chairs and the audience will actively discuss the showcased trials.

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}